As we move into the new year, some investors are starting to look for the next stock that will take the market by storm. Despite making a number of changes to its corporate model, it does not seem like TearLab Corporation (TSE:TLB) (OTCMKTS:TEAR) will be one of those stocks.
TearLab Corporation has had a busy couple of months, both in a good way and a bad way, and yet the stock was still down almost 10% on Wednesday, December 20. I can only assume this is not the way the San Diego-based company wanted to end the last couple weeks of 2017.
For those who don’t know, TearLab is both a developer and marketer of chip technologies which allow eye care practitioners to advance their standard of care.
With all of that being said, it is important to remember that just because a stock drops in price at a rapid pace does not mean that that same stock can’t rise just as fast as it fell. So how should you approach TearLab stock? Well, let’s review some of their latest announcements and reports.
In November, TearLab reported its earnings report for Q3 which ended on September 30 of this year. In terms of net loss for Q3, this came in at $3.8 million, which compares to a net loss of $4.0 million in the same period a year ago. Further, perhaps the most notable figure in the report was the company’s decline in revenue, going from $7.2 million to $6.5 million.
That said, the report had a number of highlights as well. TearLab announced that the company had increased the active U.S. user base number, and unveiled that it had made even more reductions in operating expenses.
When an individual looks at TearLab’s performance over the course of the past week, they will see that the company has performed -2.56%. Since the start of 2017, the stock has been -92.69%.
Only time will tell the direction TearLab is heading in for 2018, but if you check back with us in January, we will hopefully have more information that you will help you decide if you want to add it to your investment portfolio or not.
Featured Image: facebook
